#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuropathic arthropathy Squamous cell carcinoma of the hypopharynx Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Encephalitis autoimmune Arrhythmogenic right ventricular dysplasia Adult T-cell lymphoma/leukaemia refractory Frontotemporal dementia Trigeminal neuralgia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Thymic carcinoma Chronic graft versus host disease in liver Malignant oligodendroglioma Synovitis Hereditary angioedema Pseudomyxoma peritonei More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Treatment Brain stem glioma Pemphigoid – Diagnostics SAPHO syndrome – Diagnostics Glycogen storage disease type V – Life with Disease Wolfram syndrome – Life with Disease Nodal marginal zone B-cell lymphoma – Life with Disease Chondrosarcoma metastatic – Treatment Rett syndrome Methylmalonic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoprolol Dexamethasone Isonicotinate L-LEUCINE GUAIACOL Lutetium (177Lu) Oxodotreotide ROC-101 HYDROCHLORIDE Human Coagulation Factor X PRT3789 Munc-Cd34 Olanzapine CHOLINE ALFOSCERATE Ertapenem Ergocalciferol Bp Sot102 ZOLPIDEM TARTRATE GXV813 L-ARGININE Azenosertib Epinephrine Bitartrate IMB 101 More therapies…

    Learn about Your Condition

    Myofascial pain syndrome Conjunctivitis allergic Cluster headache Hereditary ataxia Thrombotic microangiopathy Microscopic polyangiitis Radius fracture Psychogenic seizure Lymphangiosarcoma Inguinal hernia Osteosarcoma recurrent Retinal neovascularisation Epidermolysis bullosa Psoriatic arthropathy Death neonatal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Soft tissue sarcoma

  • Phase Ib/II Study of Bexmarilimab Plus Doxorubicin in Adults with Metastatic Soft Tissue Sarcoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Bexmarilimab
    • Doxorubicin Hydrochloride
    Spain

  • Study of cobimetinib and atezolizumab combination therapy in children and adults with advanced or metastatic soft tissue sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Cobimetinib
    • Atezolizumab
    France

  • Study on Aldesleukin and Dendritic Cell Vaccine for Patients with Resected Stage IV Neuroendocrine Tumors and Soft Tissue Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Soft tissue sarcoma
    Investigated Drugs:
    • Autologous Tumor Lysate-Loaded Dendritic Cells
    • Aldesleukin
    Italy

  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Jk06
    Belgium Spain

  • Study on Ifosfamide and Doxorubicin for Patients with High-Grade Soft Tissue Sarcoma in the Limbs and Trunk Wall

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Ifosfamide
    • Doxorubicin Hydrochloride
    Norway

  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Patients with Resectable Soft-Tissue Sarcoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Dacarbazine
    • Ifosfamide
    • Doxorubicin Hydrochloride
    France
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!